RadNet Participates in Exciting Clinical Trials to Evaluate and Stage Prostate Cancer
RadNet’s Research Division has been participating in two clinical trials of a prostate-specific Positron Emission Tomography (PET) tracer in men with newly diagnosed prostate cancer and those with a recurrence of prostate cancer after having undergone previous prostate cancer treatment. Under the guidance of Judith Rose M.D., Medical Director of PET/CT and Clinical Research for RadNet, and in conjunction with Dr. David Josephson M.D. of Tower Urology, and Blue Earth Diagnostics.